FDA Withdraws Gatifloxacin from Sale Due to Safety Concerns

Summary

The US Food and Drug Administration (FDA) has made the decision to remove gatifloxacin, a medication sold under the brand name TEQUIN, from the market due to concerns over its safety and effectiveness, which will prevent the approval of new versions of the drug.